Abstract
The aim of the present chapter is to confirm the clinical expediency of utilization of particular type of biological skin substitute—porcine skin xenograft in the treatment of scald partial-thickness burns. Among 109 patients, 78 (71%) patients healed within 14 days with a mean time 9.6 days. One sample t-test which compared mean healing times achieved within 14 days with the value of 14 days proved to be significant. Four patients received split-thickness skin grafts. The data obtained were compared with similar studies, and other treatment options in this indication were discussed. The retrospective study proved the clinical efficiency of utilization of skin xenograft for the treatment of partial-thickness scald burns. This method with its treatment effect is fully comparable with the other ones, which are using biological or another type of skin substitutes in given indication.
References
Ahuja RB, Bhattacharya S (2002) An analysis of 11,196 burn admissions and evaluation of conservative management techniques. Burns 28:555–561
Pruitt BA, Wolf SE, Mason AD (2007) Epidemiological, demographic, and outcome characteristics of burn injury. In: Herndon DN (ed) Total burn care. Elsevier, Philadelphia, pp 14–32
Forjuoh SN (2006) Burns in low- and middle-income countries: a review of available literature on descriptive epidemiology, risk factors, treatment, and prevention. Burns 32:529–537
Koller J, Orság M, Ondriašová E, Gräffinger I, Bukovcan P (1994) Analysis of 1119 Burn injuries treated at the bratislava burn department during a five-year period. Acta Chir Plast 36(3):67–70
Bukovcan P, Koller J (2010) Treatment of partial-thickness scalds by skin xenografts – retrospective study of 109 cases in the three- years period. Acta Chir Plast 52(1):7–12
Moserová J, Bĕhounková E, Vrabec R, Svátek V (1974) Methods of collection and storage of porcine dermoepidermal grafts. Rozhl Chir 53(3):190–194
Brans TA, Hoekstra MJ, Vloemans AFPM, Kreis RW (1994) Long-term results of treatment of scalds in children with glycerol-preserved allografts. Burns 20:10–13
Leicht P, Muchardt O, Jensen M, Alsbjörn BA, Sørensen B (1989) Allograft vs. exposure in the treatment of scalds – a randomized controlled clinical study. Burns 15:1–3
Brown R, Smith KD, Angus McGrouther D (1997) Strategies for cell engineering in tissue repair. Wound Rep Reg 5:212–221
Git M, Toda K, Grinell F (1990) Activation of human keratinocyte migration on type 1 collagen and fibronectin. J Cell Sci 96:197–205
Ge L, Sun L, Chen J, Mao X, Kong Y, Xiong F, Wuc J, Wei H (2010) The viability change of pigskin in vitro. Burns 36:533–553
Brož L, Vogtová D, Königová R (1999) Experience with banked skin in the Prague burn centre. Acta Chir Plast 41:54–58
Atiyech BS, Hayek SN, Gunn SW (2005) New technologies for burn wound closure and healing – Review of the literature. Burns 31:94456
Pirnay JP, Vandenvelde C, Duinslaeger L, Reper P, Vanderkelen A (1997) HIV transmission by transplantation of allograft skin: a review of the literature. Burns 23(1):1–5
Kealey GP (1997) Disease transmissions by means of allograft. J Burn Care Rehabil 18:S10–S11
Hermans MHE (2014) Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: Is there a clinical difference? Burns 40:408–415
Csonge L, Pellet S, Szenes A, Istvan J (1995) Antibiotics in the preservation of allograft and xenograft skin. Burns 21(2):102–105
Boneva RS, Folks TM (2004) Xenotransplantation and risks of zoonotic infections. Ann Med 36(7):50
Wilson CA (2008) Porcine endogenous retroviruses and xenotransplantation. Cell Mol Life Sci 65(21):3399–3412
Healy CMJ, Boorman JG (1989) Comparison of E-Z Derm and Jelonet dressings for partial thickness burns. Burns 15(1):52–54
Ersek RA, Gadaria U, Surak G, Denton DR (1986) A new wound dressing that solves the retention and storage problems: a clinical history. Contemp Surg 28(3):72–79
Chiu T, Pang P, Ying SY, Burd A (2004) Porcine skin: friend or foe? Burns 30:739–741
Zajicek R, Matouskova E, Broz L, Kubok R, Waldauf P, Königova R (2011) New biological temporary skin cover Xe-Derma® in the treatment of superficial scald burns in children. Burns 37:333–337
Singh R, Purohit S, Chacharkar MP, Bhandari PS, Bath AS (2007) Microbiological safety and clinical efficacy of radiation sterilized amniotic membranes for treatment of second-degree burns. Burns 33:505–510
Rab M, Koller R, Ruzicka M, Burda G, Kamolz LP, Bierochs B, Meissl G, Frey M (2005) Should dermal scald burns in children be covered with autologous skin grafts or with allogeneic cultivated keratinocytes?—“The Viennese concept”. Burns 31:578–586
Ghaffari A, Kilani RT, Ghahary A (2009) Keratinocyte-conditioned media regulate collagen expression in dermal fibroblasts. J Invest Dermatol 129(2):340–347
DiPersio CM, Zheng R, Kenney J, Van De Water L (2016) Integrin-mediated regulation of epidermal wound functions. Cell Tissue Res 365:467–482
Ou LF, Lee SY, ChenYC YRS, Tang YW (1998) Use of biobrane in pediatric scald burns – experience in 106 children. Burns 24:49–53
Demling RH, DeSanti L (1999) Management of partial thickness facial burns (comparison of topical antibiotics and bio-engineered skin substitutes). Burns 25:256–261
Tompkins RG, Burke JF (1992) Burn wound closure using permanent skin replacement materials. World J Surg 16:47–52
Alsbjörn B, Gilbert P, Hartmann B, Kaźmiersky M, Monstrey S, Palao R, Roberto MA (2007) Van TrierA, VoinchetV. Guidelines for the management of partial-thickness burns in a general hospital or community setting – Recommendations of a European working party. Burns 33:155–160
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Bukovčan, P., Koller, J. (2017). Treatment of Partial-Thickness Scalds by Skin Xenografts. In: Shiffman, M., Low, M. (eds) Burns, Infections and Wound Management. Recent Clinical Techniques, Results, and Research in Wounds, vol 2. Springer, Cham. https://doi.org/10.1007/15695_2017_28
Download citation
DOI: https://doi.org/10.1007/15695_2017_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10685-0
Online ISBN: 978-3-030-10686-7
eBook Packages: MedicineMedicine (R0)